Trials / Completed
CompletedNCT05089357
Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin
A Prospective, Non-interventional Study to Collect Subject and Physician Satisfaction During Long Term Treatment of Glabellar Lines With Dysport® in Subjects of Chinese Origin in Real Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, longitudinal, non-interventional, multi-center study to collect subject and physician satisfaction, and treatment experience with Dysport in real clinical practice in subjects of Chinese origin.
Detailed description
Approximately 250 subjects are planned to be included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AbobotulinumtoxinA | Participants received a total dose of AbobotulinumtoxinA (Dysport®), 50 U (0.25 mL total; 10 U \[0.05 mL per injection site\] of study drug into 5 injection sites intramuscularly. |
Timeline
- Start date
- 2021-11-11
- Primary completion
- 2023-09-12
- Completion
- 2023-12-24
- First posted
- 2021-10-22
- Last updated
- 2025-07-09
- Results posted
- 2025-02-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05089357. Inclusion in this directory is not an endorsement.